Literature DB >> 18456490

Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.

Sarah M Mense1, Jaimeet Chhabra, Hari K Bhat.   

Abstract

Estrogen metabolism is suggested to play an important role in estrogen-induced breast carcinogenesis. Epidemiologic studies suggest that diets rich in phytoestrogens are associated with a reduced risk of breast cancer. Phytoestrogens are biologically active plant compounds that structurally mimic 17beta-estradiol (E(2)). We hypothesize that phytoestrogens, may provide protection against breast carcinogenesis by altering the expression of estrogen-metabolizing enzymes cytochrome P450 1A1 (Cyp1A1) and 1B1 (Cyp1B1). Cyp1A1 and Cyp1B1 are responsible for the metabolism of E(2) to generate 2-hydroxyestradiol (2-OHE(2)) and 4-hydroxyestradiol (4-OHE(2)), respectively. Studies suggest that 2-OHE(2) and 2-methoxyestradiol may protect against breast carcinogenesis, while 4-OHE(2) is carcinogenic in rodent models. Thus, agents that increase the metabolism of E(2) by Cyp1A1 to produce 2-OHE(2) may have chemoprotective properties. The human immortalized non-neoplastic breast cell line MCF10F was treated with quercetin at 10 and 50muM concentrations for time points ranging from 3 to 48h. Total RNA and protein were isolated. Real-time PCR was used to measure the expression of Cyp1A1 and Cyp1B1 mRNA. Quercetin treatment produced differential regulation of Cyp1A1 and Cyp1B1 mRNA expression in a time- and dose-dependent manner. Treatment with 10 and 50 microM doses of quercetin produced 6- and 11-times greater inductions of Cyp1A1 mRNA over Cyp1B1 mRNA, respectively. Furthermore, quercetin dramatically increased Cyp1A1 protein levels and only slightly increased Cyp1B1 protein levels in MCF10F cells. Thus, our data suggest that phytoestrogens may provide protection against breast cancer by modulating expression of estrogen-metabolizing genes such that production of the highly carcinogenic estrogen metabolite 4-OHE(2) by Cyp1B1 is reduced and the production of the less genotoxic 2-OHE(2) by Cyp1A1 is increased.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456490      PMCID: PMC2533731          DOI: 10.1016/j.jsbmb.2008.03.029

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  62 in total

1.  2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.

Authors:  R W Brueggemeier; A S Bhat; C J Lovely; H D Coughenour; S Joomprabutra; D H Weitzel; D D Vandre; F Yusuf; W E Burak
Journal:  J Steroid Biochem Mol Biol       Date:  2001-08       Impact factor: 4.292

2.  Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast.

Authors:  Charles E Wood; Thomas C Register; Adrian A Franke; Mary S Anthony; J Mark Cline
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

3.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

Review 4.  Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.

Authors:  E L Cavalieri; E G Rogan; D Chakravarti
Journal:  Cell Mol Life Sci       Date:  2002-04       Impact factor: 9.261

5.  Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.

Authors:  K P Bhat; D Lantvit; K Christov; R G Mehta; R C Moon; J M Pezzuto
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

6.  Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.

Authors:  Sanjeev Banerjee; Carlos Bueso-Ramos; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

7.  Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.

Authors:  K Cao; D E Stack; R Ramanathan; M L Gross; E G Rogan; E L Cavalieri
Journal:  Chem Res Toxicol       Date:  1998-08       Impact factor: 3.739

8.  Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.

Authors:  Zhi-Hua Chen; Yeon-Jin Hurh; Hye-Kyung Na; Jung-Hwan Kim; Young-Jin Chun; Dong-Hyun Kim; Kyung-Sun Kang; Myung-Haing Cho; Young-Joon Surh
Journal:  Carcinogenesis       Date:  2004-05-13       Impact factor: 4.944

Review 9.  Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.

Authors:  Giuseppe Galati; Peter J O'Brien
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

Review 10.  Breast cancer.

Authors:  G Ursin; L Bernstein; M C Pike
Journal:  Cancer Surv       Date:  1994
View more
  12 in total

1.  Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

Review 2.  Modulation of estrogen synthesis and metabolism by phytoestrogens in vitro and the implications for women's health.

Authors:  Majorie B M van Duursen
Journal:  Toxicol Res (Camb)       Date:  2017-09-08       Impact factor: 3.524

3.  Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Hari K Bhat
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

4.  CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract.

Authors:  Carlota Oleaga; Miriam García; Anna Solé; Carlos J Ciudad; Maria Izquierdo-Pulido; Véronique Noé
Journal:  Eur J Nutr       Date:  2011-08-06       Impact factor: 5.614

5.  Analysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS.

Authors:  Adrian A Franke; Laurie J Custer; Yukiko Morimoto; Frank J Nordt; Gertraud Maskarinec
Journal:  Anal Bioanal Chem       Date:  2011-06-29       Impact factor: 4.142

6.  Differential suppression of the aryl hydrocarbon receptor nuclear translocator-dependent function by an aryl hydrocarbon receptor PAS-A-derived inhibitory molecule.

Authors:  Jinghang Xie; Xin Huang; Miki S Park; Hang M Pham; William K Chan
Journal:  Biochem Pharmacol       Date:  2014-01-28       Impact factor: 5.858

7.  Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.

Authors:  Bhupendra Singh; Sarah M Mense; Nimee K Bhat; Sandeep Putty; William A Guthiel; Fabrizio Remotti; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-22       Impact factor: 4.219

8.  Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Leigh Murphy; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-19       Impact factor: 4.292

9.  Characterization of synergistic anti-cancer effects of docosahexaenoic acid and curcumin on DMBA-induced mammary tumorigenesis in mice.

Authors:  Rafat A Siddiqui; Kevin A Harvey; Candace Walker; Jeffrey Altenburg; Zhidong Xu; Colin Terry; Ignacio Camarillo; Yava Jones-Hall; Cary Mariash
Journal:  BMC Cancer       Date:  2013-09-13       Impact factor: 4.430

10.  Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat model.

Authors:  Akihiro Higuchi; Erina Oonishi; Tetsuya Kawakita; Kazuo Tsubota
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.